A routine change in medication can sometimes be followed by unexpected symptoms, and one medical case involving a COPD patient drew attention because of a rare inflammatory skin condition.
The patient, a 55-year-old woman with a history of chronic obstructive pulmonary disease and high blood pressure, developed painful, intensely red areas on her face and neck shortly after her inhaler treatment was changed.
What initially looked like a possible allergic or inflammatory skin problem eventually led doctors to a much less common diagnosis: Sweet syndrome.
The case highlights why sudden skin changes following a medication change should be evaluated by a healthcare professional rather than automatically being attributed to an ordinary allergy or irritation.
What Happened After the Inhaler Change?
According to the case description, the woman had previously been using an inhaler containing formoterol. Because of changes in her lung function, her treatment was switched to a combination containing indacaterol and glycopyrronium.
About two days after beginning the new medication, she developed painful, bright-red plaques on her face and neck.
She also experienced a mild fever.
The timing raised the possibility of a medication-related reaction, but there are many conditions that can produce red or inflamed skin. Doctors therefore needed to investigate the symptoms rather than relying on appearance alone.
The patient was referred for dermatological assessment, and the new inhaler was discontinued as part of the medical evaluation.
A skin biopsy subsequently supported the diagnosis of Sweet syndrome.
What Is Sweet Syndrome?
Sweet syndrome, also known as acute febrile neutrophilic dermatosis, is a rare inflammatory skin disorder.
It can appear suddenly, with painful, red or reddish-purple bumps, plaques, or swollen areas on the skin. The face, neck, upper body, and arms are among the areas that may be affected. Fever and other signs of inflammation can also occur.
The condition is associated with an abnormal inflammatory response involving neutrophils, a type of white blood cell.
The exact reason Sweet syndrome develops is not always clear.
In some people, it can occur in association with infections, inflammatory diseases, pregnancy, certain cancers, or medications. Drug-induced Sweet syndrome has been linked to several medications, although the specific triggers vary.
Why Can It Be Difficult to Recognize?
One reason Sweet syndrome can initially be difficult to identify is that its skin lesions can resemble other conditions.
Possible alternatives may include allergic or contact reactions, infections, hives, lupus, cellulitis, and other inflammatory skin disorders.
That is why a doctor may consider the patient’s recent medical history, medications, symptoms, blood tests, and sometimes a skin biopsy.
A biopsy can be particularly useful because Sweet syndrome has characteristic microscopic findings involving inflammatory cells in the skin.
In the reported case, the biopsy helped establish the diagnosis after other possibilities had been considered.
Can Medications Trigger Sweet Syndrome?
Yes. Medication-related cases of Sweet syndrome are recognized in medical literature.
Commonly reported drug triggers include certain growth factors, antibiotics and other medications. DermNet notes that drug-induced Sweet syndrome is one of the recognized forms of the condition.
Importantly, inhaled medications have also been reported in connection with Sweet syndrome. A case report published in Semergen in 2017 specifically described inhaler-associated Sweet syndrome, meaning it would be inaccurate to describe an inhaler as a completely unprecedented trigger.
That does not mean inhalers commonly cause Sweet syndrome.
Sweet syndrome remains rare, and a skin reaction after starting a medication does not automatically mean that the medication caused it.
Doctors have to consider the timing, clinical findings, other possible causes, and the patient’s medical history.
Treatment Can Produce Rapid Improvement
Treatment depends on the individual situation and the suspected cause.
When a medication is believed to be responsible, doctors may consider stopping or changing the suspected medication under appropriate medical supervision.
Systemic corticosteroids are commonly used to treat Sweet syndrome and can lead to relatively rapid improvement in fever and skin inflammation. Other treatments may be considered when corticosteroids are unsuitable or do not work adequately.
In the case described, the patient’s symptoms improved quickly after medical treatment.
That improvement was consistent with the diagnosis, although response to treatment is only one part of the overall diagnostic picture.
Sudden Skin Changes Shouldn’t Be Ignored
The case provides a useful reminder about an important medical principle: new symptoms that appear soon after a medication change deserve attention.
This does not mean that every rash is a serious drug reaction.
Many rashes are caused by common and relatively minor conditions. However, sudden painful skin lesions accompanied by fever or other systemic symptoms warrant professional assessment.
People should also avoid stopping essential prescription medication on their own unless instructed to do so by a healthcare professional. For someone with COPD, maintaining appropriate respiratory treatment is particularly important.
If a new reaction occurs after starting or changing medication, contacting the prescribing clinician or another qualified healthcare professional can help determine the safest next step.
What Symptoms May Require Prompt Attention?
Sweet syndrome itself is uncommon, so these symptoms should not be used as a way to diagnose the condition at home.
However, medical attention is appropriate for unexplained skin changes that are rapidly developing, painful, spreading, or accompanied by fever or feeling significantly unwell.
Urgent medical assessment is especially important if a suspected medication reaction involves difficulty breathing, swelling of the face or throat, fainting, extensive blistering, skin peeling, or other severe symptoms.
These signs can occur with other serious conditions and should not be ignored.
A Rare Diagnosis With an Important Lesson
The reported case is interesting because of the unusual combination of a medication change and a rare inflammatory skin disorder.
But its broader lesson is more practical.
A new medication may occasionally be followed by an unexpected symptom, and determining whether the two are actually connected requires careful medical evaluation.
Sweet syndrome can have several possible causes, and inhaler-related cases have been reported before.
For patients, the safest approach is not to assume that every new rash is an allergy or a medication side effect.
Instead, note when the symptoms began, tell the healthcare professional about any recent medication changes, and seek appropriate medical evaluation.
In unusual cases, that information can help doctors recognize a rare condition and begin the right treatment sooner.
Leave a Reply